An older adult client has been diagnosed with postmenopausal osteoporosis and has been prescribed calcitonin. The nurse should anticipate administration by what route’

Schizophrenia is a chronic and severe mental illness that requires lifelong treatment. Antipsychotic medications are the cornerstone of treatment for schizophrenia, and they work by blocking dopamine receptors in the brain. These medications are effective in reducing the positive symptoms of schizophrenia, such as hallucinations and delusions, and can also improve negative symptoms like apathy and lack of motivation.

While chlorpromazine, fluphenazine, and haloperidol are all first-generation or "typical" antipsychotic medications, they are less commonly used today due to their side effect profile, which can include movement disorders such as tardive dyskinesia. Olanzapine, on the other hand, is a second-generation or "atypical" antipsychotic medication that is commonly used today due to its efficacy in treating both positive and negative symptoms of schizophrenia, as well as its more favorable side effect profile compared to first-generation antipsychotics.

Calcitonin is a medication used to treat postmenopausal osteoporosis in older adults. It works by inhibiting bone resorption and decreasing the breakdown of bone tissue. Calcitonin is available in several forms, including intranasal spray, subcutaneous injection, and intravenous infusion. However, for the treatment of postmenopausal osteoporosis, calcitonin is most commonly administered via intranasal spray.

Intranasal calcitonin is easy to use and well-tolerated by most clients. It is absorbed through the nasal mucosa and reaches peak blood levels within 30-60 minutes after administration. The medication is usually administered once daily, alternating nostrils with each dose.

Other routes of administration, such as subcutaneous injection and intravenous infusion, may be used in certain situations, such as for the treatment of Paget's disease of bone or hypercalcemia. However, these routes of administration are less commonly used for the treatment of postmenopausal osteoporosis in older adults. The healthcare provider will determine the appropriate route of administration based on the individual client's needs and medical history.